Ledger.Open graph →
SEC Form D · filed December 5, 2016

Nohla Therapeutics Inc

Offering
$41.6M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Brian Daniels · Seattle, WADirectorSteven Gillis · Seattle, WADirectorLawrence D. Gozlan · Seattle, WADirectorDarren D. Scotti · Seattle, WAExecMichael Sistenich · Seattle, WAExec · DirectorRussell S. Fryer · Toronto, Ontario, CanadaExec · DirectorDarren D. Scotti · Seattle, WAExecRussell Holmes · San Diego, CADirectorRobert S. Klein · Toronto, Ontario, CanadaDirectorAndrew S. Wilder · Toronto, Ontario, CanadaDirectorGreg Vital · Georgetown, TNDirectorRyan Jacobs · Highland Park, ILExecPaul E. Hodges, Iii · Bloomfield Township, MIDirectorRonald D. Poe · Riva, MDExec · DirectorGeorge D. Doney · Riva, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗